Mobilization of allogeneic peripheral blood stem cell donors with intravenous plerixafor mobilizes a unique graft-Reference-Cited by-同舟云学术

Mobilization of allogeneic peripheral blood stem cell donors with intravenous plerixafor mobilizes a unique graft

Published:2017-05-11 Issue:19 Volume:129 Page:2680-2692
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Schroeder Mark A.¹,Rettig Michael P.¹,Lopez Sandra¹,Christ Stephanie¹,Fiala Mark¹,Eades William¹,Mir Fazia A.²,Shao Jin¹,McFarland Kyle¹,Trinkaus Kathryn³,Shannon William³,Deych Elena³,Yu Jinsheng⁴,Vij Ravi¹,Stockerl-Goldstein Keith¹,Cashen Amanda F.¹,Uy Geoffrey L.¹,Abboud Camille N.¹,Westervelt Peter¹,DiPersio John F.¹

Affiliation:

1. Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO;

2. Division of Hematology and Medical Oncology, Department of Internal Medicine, Saint Louis University School of Medicine, St. Louis, MO; and

3. Division of Biostatistics and

4. Department of Genetics, Washington University School of Medicine, St. Louis, MO

Abstract

Key Points Plerixafor is a safe, effective, rapid mobilizing agent when administered intravenously. Lower rates of GVHD and CMV viremia with plerixafor-mobilized grafts may be related to a unique cellular composition of the graft.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/129/19/2680/1400581/blood739722.pdf

Reference35 articles.

1. Stem Cell Trialists’ Collaborative Group. Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials;J Clin Oncol,2005

2. Allogeneic bone marrow transplantation compared to peripheral blood stem cell transplantation for the treatment of hematologic malignancies: a meta-analysis based on time-to-event data from randomized controlled trials;Chang;Ann Hematol,2012

3. Mobilized peripheral blood stem cells compared with bone marrow as the stem cell source for unrelated donor allogeneic transplantation with reduced-intensity conditioning in patients with acute myeloid leukemia in complete remission: an analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation;Nagler;Biol Blood Marrow Transplant,2012

4. Blood graft composition after plerixafor injection in patients with NHL;Varmavuo;Eur J Haematol,2012

5. Mobilization of hematopoietic stem and progenitor cells using inhibitors of CXCR4 and VLA-4;Rettig;Leukemia,2012

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of VLA4 and CXCR4 Antagonists for the Mobilization of Hematopoietic Stem and Progenitor Cells;Biomolecules;2024-08-14

2. Effect of voxelotor on murine bone marrow and peripheral blood with hematopoietic progenitor cell mobilization for gene therapy of sickle cell disease;Blood Cells, Molecules, and Diseases;2024-03

3. Hematopoietic stem cell collection for sickle cell disease gene therapy;Current Opinion in Hematology;2024-02-09

4. Updates on the mobilization pipeline for hematopoietic stem cell collection;Journal of Clinical Apheresis;2023-09-25

5. Hematopoietic stem cell mobilization for allogeneic stem cell transplantation by motixafortide, a novel CXCR4 inhibitor;Blood Advances;2023-09-13